Next Big European IPO Is In Medical Diagnostics

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

March 15, 2018, 9:39 PM UTC

Siemens AG’s big IPO is in the pipeline and due to begin trading March 16, 2018. They are making a big bet on selling equipment that analyzes blood and other medical samples. Ironically it’s a segment of their business that hasn’t enjoyed much success, and comes at the same time they launched a new diagnostics brand (Atellica) that is meant to replace older products that are also less than successful. Competitors Roche Holdings and Abbott Laboratories continue to outperform Siemens, so a lot is riding on this IPO bet.

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

Start free Book a demo

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace

One video edit a month, on us

AI writing, editing, and publishing tools

In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

01UpDoc's diabetes management app receives FDA clearance.
02Aidoc achieves breakthrough device status for AI radiology reports.
03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

01First wave of AI increased productivity in healthcare.
02Second wave aims to restructure job roles.
03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

0180% of US factories have no automation.
02Medtech manufacturers are investing in automation technologies.
03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For Healthcare teams

See how Healthcare teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›

Keep exploring

More from Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512